Difference between revisions of "Yang Y, et al. Mol. Cancer (2017) cited as Ref 338 in DOI: 10.1038/s41392-020-0110-5 (Q9601)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 28830450, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 141-, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2017
Timestamp+2017-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2017 / rank
 +
Normal rank
Property / Published In Name String
 +
Mol. Cancer
Property / Published In Name String: Mol. Cancer / rank
 +
Normal rank
Property / Volume
 +
16
Property / Volume: 16 / rank
 +
Normal rank
Property / title
 +
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis (English)
Property / title: MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis (English) / rank
 +
Normal rank
Property / Page(s)
 +
141-
Property / Page(s): 141- / rank
 +
Normal rank

Latest revision as of 15:38, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Yang Y, et al. Mol. Cancer (2017) cited as Ref 338 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Yang Y
    0 references
    0 references
    2017
    0 references
    Mol. Cancer
    0 references
    16
    0 references
    MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis (English)
    0 references
    141-
    0 references